Literature DB >> 19539520

Synthesis, characterization and antimicrobial activity of 3d transition metal complexes of a biambidentate ligand containing quinoxaline moiety.

P V Anantha Lakshmi1, P Saritha Reddy, V Jayatyaga Raju.   

Abstract

A new series of oxovanadium(IV), chromium(III), manganese(II), iron(III), cobalt(II), nickel(II), and copper(II) complexes of the 3-hydrazino quinoxaline-2-one (HQO) were prepared and characterized. The ligand exhibits biambidenticity. It behaves as a bidentate ON donor in oxovanadium(IV), iron(III) and copper(II) complexes and as a bis bidentate ONNN donor in chromium(III), manganese(II), cobalt(II) and nickel(II) complexes. The nature of bonding and the stereochemistry of the complexes have been deduced from elemental analyses, thermal, infrared, (1)H NMR, electronic spectra, magnetic susceptibility and conductivity measurements. An octahedral geometry was suggested for all the complexes. All the complexes show subnormal magnetic moments. The ligand, HQO, and its complexes were tested against one strain Gram +ve bacteria (Staphylococcus aureus), Gram -ve bacteria (Escherichia coli). The prepared metal complexes exhibited higher antimicrobial activities than the parent ligand.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19539520     DOI: 10.1016/j.saa.2009.05.007

Source DB:  PubMed          Journal:  Spectrochim Acta A Mol Biomol Spectrosc        ISSN: 1386-1425            Impact factor:   4.098


  2 in total

1.  Synthesis and Assessment of Antibacterial Activities of Ruthenium(III) Mixed Ligand Complexes Containing 1,10-Phenanthroline and Guanide.

Authors:  Atakilt Abebe; Tizazu Hailemariam
Journal:  Bioinorg Chem Appl       Date:  2016-10-19       Impact factor: 7.778

2.  Oxidative stress and antimicrobial activity of chromium(III) and ruthenium(II) complexes on Staphylococcus aureus and Escherichia coli.

Authors:  Paulina L Páez; Claudia M Bazán; María E Bongiovanni; Judith Toneatto; Inés Albesa; María C Becerra; Gerardo A Argüello
Journal:  Biomed Res Int       Date:  2013-09-04       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.